- Ticker
- ABIO
- Price
- 2.05
- Stock movement down
- -0.06 (-2.84%)
- Company name
- ARCA Biopharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Marktkapitalisatie
- 29.54M
- Ent waarde
- -12.16M
- Prijs/Verkoop
- -
- Prijs/Boek
- 0.69
- Div opbrengst
- -
- Div groei
- -
- Jaren van groei
- -
- FCF-uitkering
- -
- Trailing P/E
- -
- Toekomstige P/E
- -
- PEG
- -
- EPS-groei
- -
- 1 jaar rendement
- -13.87%
- 3 jaar rendement
- -7.62%
- 5 jaar rendement
- -28.70%
- 10 jaar rendement
- -40.13%
Laatst bijgewerkt: 2023-03-22
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
28 oktober 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2 augustus 2022
iO Charts is a Seeking Alpha partner
DIVIDENDEN
ABIO keert geen dividend uit
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2 augustus 2022
iO Charts is a Seeking Alpha partner
Activist is pushing ARCA biopharma to stop new developments and return cash to shareholders. Click here to learn more about ABIO stock.
3 mei 2022
iO Charts is a Seeking Alpha partner
WAARDERING
Waarderingsverhoudingen
Loading...
Gegevens over waarderingsratio's
| Trailing P/E | - |
| Prijs tot OCF | - |
| Prijs tot FCF | - |
| Prijs tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (verkoop/boekwaarde)
Loading...
Waarderingsgegevens (verkoop/boekwaarde)
| Prijs tot verkoop | - |
| Prijs te boeken | 0.69 |
| EV naar verkoop | - |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2 mei 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
18 april 2022
iO Charts is a Seeking Alpha partner
FINANCIËN
Per aandeel
Loading...
Gegevens per aandeel
| Huidig aantal aandelen | 14.41M |
| WPA (TTM) | -1.00 |
| FCF per aandeel (TTM) | -1.00 |
Resultatenrekening
Loading...
Gegevens van de resultatenrekening
| Inkomsten (TTM) | 0.00 |
| Brutowinst (TTM) | 0.00 |
| Bedrijfsresultaat (TTM) | -14.73M |
| Netto inkomsten (TTM) | -14.43M |
| WPA (TTM) | -1.00 |
| Winst per aandeel (1 jaar vooruit) | - |
Marges
Loading...
Margegegevens
| Brutomarge (TTM) | - |
| Operationele marge (TTM) | - |
| Winstmarge (TTM) | - |
Balans
Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Balansgegevens
| Cash | 43.94M |
| Netto vorderingen | 0.00 |
| Totaal vlottende activa | 44.55M |
| Goodwill | 0.00 |
| Immateriële activa | 0.00 |
| Materiële vaste activa | 0.00 |
| Totaal activa | 44.97M |
| Crediteuren | 593.00K |
| Schuld op korte/lange termijn | 301.00K |
| Totaal vlottende passiva | 1.94M |
| Totaal passiva | 2.24M |
| Eigen vermogen | 42.73M |
| Netto materiële activa | 42.73M |
Kasstroom
Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Kasstroomgegevens
| Bedrijfskasstroom (TTM) | -14.37M |
| Investeringsuitgaven (TTM) | 9.00K |
| Vrije kasstroom (TTM) | -14.37M |
| Betaalde dividenden (TTM) | 0.00 |
Financieel rendement
Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Gegevens over financieel rendement
| Rendement op eigen vermogen | -33.77% |
| Rendement op activa | -32.09% |
| Rendement op geïnvesteerd kapitaal | -33.77% |
| Contant rendement op geïnvesteerd kapitaal | -33.64% |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
31 maart 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
14 maart 2022
iO Charts is a Seeking Alpha partner
VOORRAADINFORMATIE
Voorraadgrafiek
Loading...
Koersgegevens
| Open | 2.10 |
| Dagelijks hoog | 2.10 |
| Dagelijks laag | 2.05 |
| Dagelijks volume | 15K |
| Hoogtepunt aller tijden | 5726700.00 |
| 1y analistenraming | 7.00 |
| Beta | 1.64 |
| WPA (TTM) | -1.00 |
| Dividend per aandeel | - |
| Ex-div datum | 1 May 2006 |
| Volgende inkomsten datum | 1 May 2023 |
Negatief potentieel
Loading...
Nadeel potentiële gegevens
| ABIO | S&P500 | |
| Huidige prijsdaling vanaf het hoogste punt ooit | -100.00% | -17.92% |
| Hoogste prijsdaling | -100.00% | -56.47% |
| Datum van hoogste daling | 22 Mar 2023 | 9 Mar 2009 |
| Gemiddelde daling vanaf de top | -93.88% | -11.51% |
| Gemiddelde tijd tot nieuwe high | 280 days | 13 days |
| Max tijd tot nieuwe hoogte | 5809 days | 1805 days |
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2 december 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
2 november 2021
iO Charts is a Seeking Alpha partner
BEDRIJFSGEGEVENS
Marketcap
29.54M
Marketcap categorie
Small-cap
Beschrijving
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Werknemers
17
Website
Investeerdersrelaties
-
SEC-dossiers
CEO
Michael R. Bristow
Land
USA
Stad
Westminster
Type voorraad
Common stock
CCC-status
-
Dividendfrequentie
-
EVENEMENTEN EN PRESENTATIES
EvenementenPresentaties
Loading...
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
28 oktober 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
16 september 2021
iO Charts is a Seeking Alpha partner
HET BEDRIJF BEGRIJPEN
Loading...
The following slide deck was published by ARCA biopharma, Inc.
23 augustus 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
9 augustus 2021
iO Charts is a Seeking Alpha partner
BEDRIJFSNIEUWS
Alle nieuwsPersberichten
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE...
24 februari 2023
We can readily understand why investors are attracted to unprofitable companies. For example, although...
3 februari 2023
WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined its Board of Directors. “We are pleased to welcome James Flynn to ...
19 december 2022
Viewing insider transactions for ARCA biopharma, Inc.'s ( NASDAQ:ABIO ) over the last year, we see that insiders were...
14 november 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Oct. 28, 2022 (GLOBE NEWSWIRE...
28 oktober 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Aug. 02, 2022 (GLOBE NEWSWIR...
2 augustus 2022
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
18 juli 2022
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors. “We are pleased to welcome Jacob Ma-We...
21 juni 2022
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that it has retained Ladenburg Thalmann & Co. Inc. to act as its financial advisor. In April 20...
5 mei 2022
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., May 02, 2022 (GLOBE NEWSWIRE...
2 mei 2022
Volgende pagina
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
4 augustus 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from ARCA biopharma, Inc. (ABIO) stock at Seeking Alpha.
13 juli 2021
iO Charts is a Seeking Alpha partner